CryoCord
CryoCord is a Malaysia-based private stem cell bank founded in 2002, headquartered in Selangor, that offers cord blood and tissue banking services to families using modern processing technology and secure long-term cryogenic storage facilities.
- Company typePrivate
- Founded2002
- HeadquartersSelangor, Malaysia
- Headcount51–100
- GTM typeB2C
- OfferingServices
What CryoCord does
CryoCord is a Malaysia-based private stem cell bank founded in 2002 and headquartered in Selangor. The company offers stem cell banking services that leverage modern processing technology and secure storage facilities, serving consumers — typically expectant parents banking newborn cord blood and tissue for potential future medical use. As a for-profit, privately-held operator with a workforce in the 51–100 range, CryoCord sits in a niche consumer healthcare services category where revenue is generated through one-time enrollment fees combined with long-term storage contracts.
The business model is consistent with the broader cord blood banking industry: customers pay an upfront collection and processing fee followed by recurring annual storage fees, producing a recurring revenue tail that compounds as the installed customer base grows. CryoCord's headcount of 51–100 employees is consistent with mid-scale laboratory operations, cryogenic storage management, and a consumer-facing sales/marketing function targeting Malaysian families and, potentially, regional cross-border clients.
The company operates under a single identified leader — Managing Director James Then Khong Lek — and the public-facing website (cryocord.com.my) currently presents only a verification/loading interface rather than substantive marketing or technical content, which limits visibility into current pricing, facility footprint, partnerships, and product differentiation. No publicly disclosed funding rounds, acquisitions, partnerships, certifications, or regulatory actions were captured in the source data.
CryoCord firmographics
Firmographics- Name
- CryoCord
- Website
- https://cryocord.com.my
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- CryoCord is a Malaysia-based private stem cell bank founded in 2002, headquartered in Selangor, that offers cord blood and tissue banking services to families using modern processing technology and secure long-term cryogenic storage facilities.
- Ownership category
- akta.pro rank
CryoCord industry classification
Industry- Product category
- Stem Cell Banking
- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industry
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)
Keywords
Where CryoCord is headquartered
LocationHeadquarters
- HQ city
- Selangor
- HQ country
- Malaysia
- HQ region
- Asia
Markets served
CryoCord business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales
CryoCord product offering
Product offeringCore offering
CryoCord is a stem cell bank that provides stem cell collection, processing, and long-term cryogenic storage services to families. It utilizes modern technology supported by advanced and secure facilities to preserve biological samples for future medical use. The company is based in Selangor, Malaysia, and operates as a private for-profit family cord blood and stem cell bank.
Product overview
No product information available in the source data. The source page displays only a loading/verification message and does not contain any substantive content about CryoCord's products, services, or company offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Stem cell banking service End-to-end family stem cell banking: collection, processing and long-term cryogenic storage of cord blood and related biological samples for individual (family) customers in Malaysia, intended to preserve stem cells for potential future medical use.
Companies that use CryoCord
Customer profileIdeal customer profiles1 record
CryoCord technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CryoCord partnerships and signals
Strategic signalRecent moves1 record
CryoCord competitors and assessment
Company assessmentRegional players
- China Cord Blood Corporation: Largest cord blood banking operator in China, with licences in multiple provinces. Comparable in core cord blood storage service but operates in a distinct regulatory and demographic geography from CryoCord.
Broad incumbents
- Global Cord Blood Corporation: Operator of multiple cord blood banks in Asia (including collaborations in China and Southeast Asia). Comparable as a multi-market, established cord blood banking platform with broader geographic reach than CryoCord.
Direct peers
- Smart Cells International: UK-based cord blood stem cell bank, one of the longest-established private family banking services in Europe. Comparable in core proposition and customer demographic, and a useful benchmark for operational longevity in the niche.
- Vita 34: Germany-listed stem cell bank offering umbilical cord blood and tissue storage plus related diagnostics. Directly comparable in business model — family banking with recurring annual storage fees and similar regulatory/compliance overhead.
- Cellsafe International: Malaysia-based stem cell bank offering cord blood and tissue storage services directly to Malaysian expectant parents. The closest head-to-head domestic competitor to CryoCord, sharing market, regulation, and customer base.
- StemCyte: Global cord blood bank with both family-banking and public-banking operations. Directly comparable in core service (umbilical cord blood/tissue cryopreservation) and in serving both consumer and clinical/therapeutic end markets.
- Future Health Biobank: UK-headquartered stem cell bank offering cord blood, cord tissue, and peripheral blood stem cell storage. Directly comparable to CryoCord in core storage proposition and in selling long-duration cryopreservation services to families.
- Cryoviva: Stem cell bank operating across South and Southeast Asia offering cord blood and cord tissue storage. Highly comparable to CryoCord in service mix, target customer (expectant parents), and regional footprint.
- Cordlife Group: Singapore-headquartered, regionally listed stem cell bank with operations across Southeast Asia including Malaysia. Directly comparable to CryoCord as a cord blood/tissue banking service provider targeting parents in the same ASEAN geography.
- Cells4Life: UK-based cord blood and tissue bank operating multiple processing/storage sites. Comparable in service portfolio (whole cord blood, cord tissue, cell type splits) and in targeting expectant parents with premium storage offerings.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
CryoCord social profiles
Digital presenceCryoCord financial estimates
Financial estimateRevenue estimate
Valuation estimate
CryoCord leadership team
Management profileNumber of profiles
Profiles1 record
CryoCord funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CryoCord M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CryoCord
What does CryoCord do?
CryoCord is a stem cell bank that provides stem cell collection, processing, and long-term cryogenic storage services to families. It utilizes modern technology supported by advanced and secure facilities to preserve biological samples for future medical use. The company is based in Selangor, Malaysia, and operates as a private for-profit family cord blood and stem cell bank.
When was CryoCord founded?
CryoCord was founded in 2002. It employs 51 to 100 people.
Where is CryoCord based?
CryoCord is headquartered in Selangor, Malaysia, in the Asia region.
Who are CryoCord's main competitors?
China Cord Blood Corporation is listed as a regional player. Global Cord Blood Corporation is listed as a broad incumbent. Direct peers are Smart Cells International, Vita 34, Cellsafe International, StemCyte, Future Health Biobank, Cryoviva, Cordlife Group and Cells4Life.
Does CryoCord have an API?
No public API is recorded for CryoCord.
What industry is CryoCord in?
CryoCord's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 621991.